CELL THERAPY USING EMBRYONIC STEM CELL SOURCE IN CLINICAL TRIAL STUDIES: ADVANTAGES AND LIMITATIONS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

GOLCHIN ALI; NIKNEJAD HASAN

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES Year:2017 | Volume:27 | Issue:148 Page(s): 161-175

Download Full-Text

Persian Verion

View:

1,188

Download:

Cites:

Information Journal Paper

Title

CELL THERAPY USING EMBRYONIC STEM CELL SOURCE IN CLINICAL TRIAL STUDIES: ADVANTAGES AND LIMITATIONS

Author(s)

GOLCHIN ALI | NIKNEJAD HASAN | Issue Writer Certificate

Keywords

EMBRYONIC STEM CELLSQ3

CELL THERAPYQ1

ADVANTAGEQ1

LIMITATIONSQ2

Abstract

Background and purpose: The unique characteristics and potency of stem cells have attracted interest for their use in CELL THERAPY. However, the use of these cells has some LIMITATIONS and problems such as ethical issues. The aim of this study was to perform a systematic review on the use of embryonic stem cell for clinical therapy targets and investigating its ADVANTAGEs and LIMITATIONS.Materials and methods: Data was collected from electronic databases including PubMed, Science direct, Medline, Clinical trial.gov, SID, etc. The search keywords included pluripotent stem cell, Embryonic stem cell (eSC), and stem CELL THERAPY.Results: Study of published articles and ongoing studies showed that pluripotency, cell viability and low immunogenicity of eSC are amongst the major reasons for their use.onclusion: Recent developments in clinical application of eSC make them a major candidate in using stem cells alongside MSC and iPS. But, further studies are needed due to its importance in many aspects.

Cites

No record.

References

Cite

APA: Copy

GOLCHIN, ALI, & NIKNEJAD, HASAN. (2017). CELL THERAPY USING EMBRYONIC STEM CELL SOURCE IN CLINICAL TRIAL STUDIES: ADVANTAGES AND LIMITATIONS. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 27(148), 161-175. SID. https://sid.ir/paper/45031/en

Vancouver: Copy

GOLCHIN ALI, NIKNEJAD HASAN. CELL THERAPY USING EMBRYONIC STEM CELL SOURCE IN CLINICAL TRIAL STUDIES: ADVANTAGES AND LIMITATIONS. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2017;27(148):161-175. Available from: https://sid.ir/paper/45031/en

IEEE: Copy

ALI GOLCHIN, and HASAN NIKNEJAD, “CELL THERAPY USING EMBRYONIC STEM CELL SOURCE IN CLINICAL TRIAL STUDIES: ADVANTAGES AND LIMITATIONS,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 27, no. 148, pp. 161–175, 2017, [Online]. Available: https://sid.ir/paper/45031/en

Related Journal Papers